LIVE IN-PERSON: Molecular Otology (June 1-2, 2026)

<< Return to Courses

Pediatric care is changing and improving all the time and it can be difficult for healthcare providers to stay on top of the newest practices, treatments, and approaches. Professionals are challenged to stay current in the innovations and advances that can lead to better outcomes and improve the quality of care for children, as well as the latest social challenges facing children. What’s more, it can be hard to find time to explore important issues such as medical ethics, office practice, medical home and well care.

$400.00

Description

Overview

This groundbreaking course is the first of its kind and draws upon the extensive experience of the Boston Children’s team, which has successfully conducted multiple sponsored multi-site clinical trials for gene therapy related to hearing loss. These trials present complexity in terms of diagnostics and the surgical procedures involved. Our goal is to offer hands-on experience to surgeons in training and those already in practice, enabling them to better assess and treat patients who may qualify for these clinical trials.

Course Format 

 

 

Learning Objectives: 

At the conclusion of this educational program, learners will be able to:

  1. To understand required clinical diagnostic evaluation for children undergoing consideration for gene therapy for hearing loss.
  2. To describe the most commonly used viral vectors and promoters used for inner ear gene therapy.
  3. To gain practical, hands on expertise to surgical approaches to gene therapy of the inner ear.
Registration

To register, please click on the register tab above. If this is your first time registering for a conference at Boston Children’s Hospital, you will need to create an account. Returning users can log in to their account to complete the registration process.   

 

 Registration Type Rate
 General Registration  $400.00

Pre-registration is required. Once you have registered you will receive a confirmation email with a registration receipt. Course access instructions will be sent a few days prior to the course launch. If you have questions or need assistance with registration, please direct all inquiries to cmedepartment@childrens.harvard.edu.

Online Course Cancellation, Transfer & Refund Policy

Due to the propriety materials and content of each course, online virtual courses orders are NOT eligible for refund, cancellation or transfer.

Other Terms and Conditions:
Online training courses may NOT be transferred to another Participant. Participants have 2 weeks to access any virtual online course content. Participants have until the expiration date to access and complete any enduring material courses. Boston Children’s Hospital CE is not responsible for user technical difficulties including loss of internet, power outages, etc. 

Cancellation of Services
Although highly unlikely, in case an event is canceled or postponed, Boson Children’s can provide a full refund or offer a credit towards future events to those who have already registered.

Refund Policy
Refunds will be made in the following ways: For payments received by credit or debit cards, the same credit/debit card will be refunded.

Accreditation

In support of improving patient care, Boston Children’s Hospital is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

 

 

 

Physician

Boston Children’s Hospital designates this live activity for a maximum of 16.00 AMA PRA Category 1 Credits ™. Physicians should claim only credit commensurate with the extent of their participation in this activity. 

Disclosure Policy 
Boston Children’s Hospital adheres to all ACCME Essential Areas, Standards, and Policies. It is Boston Children’s policy that those who have influenced the content of a CE activity (e.g. planners, faculty, authors, reviewers and others) disclose all relevant financial relationships with commercial entities so that Boston Children’s may identify and resolve any conflicts of interest prior to the activity. These disclosures will be provided in the activity materials along with disclosure of any commercial support received for the activity. Additionally, faculty members have been instructed to disclose any limitations of data and unlabeled or investigational uses of products during their presentations.

Disclosure Statement

The following planners, speakers, and content reviewers, on behalf of themselves, have reported the following relevant financial relationships with any entity producing, marketing, reselling, or distributing health care goods or services consumed by, or used on patients:

Mitigation of Relevant Financial Relationships

Boston Children’s Hospital adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Additional information

Credit Type

, ,

Duration

Format

Topic

, , , , ,

Expiration Date

Release Date

Profession

, , ,

Faculty

wendy chung headshotWendy Chung, MD
Chief, Department of Pediatrics, Boston Children’s Hospital; Professor of Pediatrics, Harvard Medical School

 

 

 

Elena Crestani headshotElena Crestani, MD
Attending Physician, Allergy and Asthma Program, Boston Children’s Hospital; Assistant Professor of Pediatrics, Harvard Medical School

 

 

Phyllis Dennery headshotPhyllis Dennery, MD
Attending Physician, Allergy and Asthma Program, Boston Children’s Hospital; Assistant Professor of Pediatrics, Harvard Medical School

 

 

 

Hannah Fassel Justus headshotHannah Fassel Justus, MD
Hematology/Oncology, Hasbro Children’s Hospital

 

 

 

Kenan Haver headshotKenan Haver, MD
Director, Asthma Program, Boston Children’s Hospital; Associate Professor of Pediatrics, Harvard Medical School

 

 

Alison Manning headshotAlison Manning, MD
Psychiatrist, Hasbro Children’s Hospital, Bradley Hospital

 

 

 

Jason Shapiro headshotJason Shapiro, MD
Director, Pediatric Inflammatory Bowel Disease Center, Hasbro Children’s Hospital

Schedule

Wednesday, December 4, 2024 Day 2 Day 3
Morning Sessions: Human Genetics and Diagnostics
Introduction & ‘How We Got Here’
8:00AM – 9:00AM
Eliot Shearer, MD PhD
Hubert Löwenheim, MD
Genetics of Hearing Loss
9:00AM – 10.00AM
Dylan Chan, MD, PhD
Diagnostic Evaluation/Workup and Cases
10:00AM – 11:00AM
Sharon Cushing, MD, MSc
Genetic Counseling for Clinical Trials for Gene Therapy
11:00AM – 11:30AM
Shelby Redfield, MS CGC
Round Table Discussion: Patient Examples
11:30AM – 12:00PM
Eliot Shearer, MD PhD
Lunch
12:00PM – 1:00PM
Afternoon Sessions: Rational Gene Therapy Design
Vectors and Promotor Choice
1:00PM – 2:00PM
Gene Replacement Therapy Design
2:00PM – 3:00PM
Gene Editing/Gene Knockdown (ASO) Design
3:00PM – 4:00PM
Gwen Géléoc, PhD
Animal Models and Organoids: Strength and Weaknesses
4:00PM – 5:00PM
Thore Schade-Mann, MD
Karl Koehler, PhD
BANQUET
5:00PM

Exhibitors/Sponsors

This is where exhibitor content goes.